NFKB1 and portal hypertension: Whole exome sequencing (WES) was conducted by next-generation sequencing (NGS) in all 11 patients suffering from portal hypertension (CVID+PH), revealing a pathogenic mutation for NFKB1 in patient #3 and CTLA4 haploinsufficiency in patient #10.